An observational study in Rotator Cuff Repair of the Shoulder, sponsored by The Cleveland Clinic. Recruiting at 2 sites in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-08-28.
Sponsored by The Cleveland Clinic · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 168 studies in Rotator Cuff Injuries with a site in United States — 40 open to participants now, 50 under way, none of them phase 3. Rotator Cuff Injuries · United States.
Among the 168 studies in Rotator Cuff Injuries with a site in United States, this one is the 21st largest by planned enrollment of the 38 observational ones that give a count, is one of 11 that started in 2025, is one of 38 observational ones, reaches primary completion later than 47 of the 49 other live ones, and was the 159th registered.
632 studies on the registry are indexed under Rotator Cuff Injuries; 157 are open to participants now.
Browse Rotator Cuff Injuries studies →40 of the 168 studies in Rotator Cuff Injuries with a site in United States are open now. Recruiting first, the newest first:
Joseph W. Galvin · Sites in United States
Ages 18–99
Tego Science, Inc. · Sites in United States
Ages 18+
ZuriMED Technologies Inc. · Sites in United States
Ages 30–70
University Hospitals Cleveland Medical Center · Sites in United States
Ages 18–89
Anika Therapeutics, Inc. · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 100 Rotator Cuff Injuries studies recruiting now, 40 (40%) set no upper age limit and 41 (41%) stop at 75 or younger; 9 take children under 18; 10 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
168 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 11 · Phase 2 11 · Phase 3 5 · Phase 4 22
First in 2005; this study’s year is marked. 11 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 65 is close to the median of 71 across 146 observational studies indexed under Rotator Cuff Injuries.
Median enrollment 60 across the 130 interventional studies, 77 across the 38 observational. Of the 86 that completed or were terminated, 29 (34%) have results posted.
This tab as a report to print or save as PDF → With an account.
40 of 168 have an industry lead sponsor. The 10 most frequent:
The Cleveland Clinic is the lead sponsor of 832 studies on the registry; 119 are open to participants now.
Of its 90 completed or terminated interventional studies of FDA-regulated products, 73 (81%) have results posted.
The Cleveland Clinic has 3 studies filed under Rotator Cuff Injuries — fewer than ten, so there is no comparison to draw.
29 of the studies in Rotator Cuff Injuries with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06735170University of MinnesotaTuberoplasty Versus Balloon Spacer | 2026-11-26 |
| NCT07851233Rothman Institute OrthopaedicsPatient Education and Sling Use After Shoulder Surgery | 2026-11-30 |
| NCT06039345University of UtahShoulder RFA Pilot Study | 2026-12 |
| NCT05011331Rhode Island HospitalThe Effect of a Custom Pillow on Sleep Quality in Patients With Nonoperative Rotator Cuff Syndrome | 2026-12 |
| NCT06669741Texas Bone and JointClinical Outcomes Related to Arthroscopic Rotator Cuff Repair Recovery Using Incrediwear | 2026-12-01 |
Add all 29 to your calendar (.ics) → With an account.
Among the 168 studies in Rotator Cuff Injuries with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
We will enroll up to 65 patients undergoing primary arthroscopic rotator cuff repair (RCR) using ActivBraid™Collagen Co-Braid suture (Zimmer Biomet) and evaluate RCR healing as well as shoulder range of motion, strength, and patient-reported outcomes at 6m, 1y and 2y.
Patients undergoing primary arthroscopic rotator cuff repair
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients undergoing primary arthroscopic rotator cuff repair will have their repair completed with ActivBraid™Collagen Co-Braid suture (Zimmer Biomet).
Device: ActivBraid™Collagen Co-Braid suture (Zimmer Biomet)
ActivBraid™ is a suture made from approximately half ultra-high molecular weight polyethylene and and half collagen derived from cow skin. Collagen is the most abundant protein in our bodies and serves as the building block for tendons and bones. The collagen in ActivBraid™ is intended to enhance cell attachment and tissue integration which may improve the healing of a rotator cuff repair. ActivBraid™ suture has been shown to have equivalent strength as other high strength sutures used in orthopaedic procedures and has been approved by the Food and Drug Administration (FDA) for repairing tendons. ActivBraid™ is a commercially available product that has been and is used in humans. This is the first post-market clinical study with ActivBraid™.
Rotator cuff repair healing
Patients will undergo magnetic resonance imaging (MRI) of the shoulder from which healing of their rotator cuff repair will be classified using Sugaya score from 1-5, where higher score indicated worse healing.
Time frame: 1 year post-operation
Rotator cuff repair healing
Patients will also undergo computed tomography (CT) scans of the shoulder from which tendon retraction of the rotator cuff repair will also be measured in millimeters where higher tendon retraction indicates worse healing.
Time frame: 1 year post-operation
Patient-reported outcome measures
Patients will be asked to answer the American Shoulder and Elbow Surgeons (ASES) Score from 0-100 points where higher score indicates better outcome.
Time frame: 1 year post-operation
Shoulder strength
Isometric shoulder strength in pounds will be assessed using a table mounted dynamometer.
Time frame: 1 year post-operation
Shoulder range of motion
Shoulder range-of-motion will be assessed by asking patients to lift their affected arm overhead in the scapular plane and measuring the range with a manual goniometer (degrees).
Time frame: 1 year post-operation
Plan to share: No
Started Aug 2025 (actual). Primary completion is estimated for Aug 2029, 48 months after the start.
Of 56 non-industry observational studies under Rotator Cuff Injuries, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 67. This study's planned 48 months is above that.
Counting every sponsor, half of 71 studies reached it within 46 months; a quarter within 17 and three quarters within 165.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.